Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1989;74:775-780
© 1989 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TURNER, D. A.
Right arrow Articles by WHARTON, A T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TURNER, D. A.
Right arrow Articles by WHARTON, A T.

The Prognostic Significance of Peritoneal Cytology for Stage I Endometrial Cancer

DEBORAH A. TURNER, MD, DAVID M. GERSHENSON, MD, NEELY ATKINSON, PhD, NOUR SNEIGE, MD and A TAYLOR WHARTON, MD

From the Department of Gynecology, Vie University of Texas M. D. Anderson Cancer Center, Houston, Texas

Abstract

A retrospective study of 567 patients treated for surgical stage I endometrial cancer was undertaken to resolve the controversy over the significance of malignant peritoneal cytology findings in early-stage disease. Twenty-eight women (4.9%) had peritoneal cytology positive for malignant cells. Comparisons were made between the groups with positive and negative cytology. Subgroups used in analysis included stage according to the International Federation of Gynecology and Obstetrics, treatment regimen, histology, grade, depth of myometrial invasion, and cervical Papanicolaou smear results. Cervical smear status was the only subgroup in which a statistically significant difference was found, with the positive peritoneal cytology patients having a higher incidence of positive Papanicolaou smears (P=.01). Forty-nine women (8.6%) developed recurrent tumor, 7% of the negative-cytology group and 32% of the positive-cytology group (P=.0002). The progression-free survival rate was lowered significantly by positive peritoneal cytology (P<.0001); patients with negative peritoneal cytology had a significantly better 5-year survival rate, 96 versus 84% (P=.0001). When multivariate analysis was performed on the 477 cases that had no missing values, peritoneal cytology remained significant for both survival rate (P=.01) and progression-free interval (P=.002). Positive peritoneal cytology is a poor prognostic factor for patients with surgical stage I endometrial cancer




This article has been cited by other articles:


Home page
Arch SurgHome page
M. Konishi, T. Kinoshita, T. Nakagohri, K. Inoue, T. Oda, and S. Takahashi
Prognostic Value of Cytologic Examination of Peritoneal Washings in Pancreatic Cancer
Arch Surg, April 1, 2002; 137(4): 475 - 480.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
Y. HIRAI, N. TAKESHIMA, T. KATO, and K. HASUMI
Malignant Potential of Positive Peritoneal Cytology in Endometrial Cancer
Obstet. Gynecol., May 1, 2001; 97(5): 725 - 728.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American College of Obstetricians and Gynecologists.